Resmed (RSMDF) Finished Goods (2010 - 2026)
Resmed's (RSMDF) quarterly Finished Goods came in at $547.0 million in Q2 2026, down 1.94% on a YoY basis from $557.9 million in Q2 2025, and down 2.14% quarter-over-quarter from $559.0 million in Q1 2026.
Analysis
Resmed (RSMDF) Finished Goods (2010 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Finished Goods for 17 consecutive years, with $547.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Finished Goods fell 1.94% year-over-year to $547.0 million; the trailing twelve-month figure through Jun 2026 stood at $547.0 million (down 1.94% YoY), and the FY2026 full-year result was $547.0 million, down 1.94% from the prior year.
- Finished Goods eased to $547.0 million in Q2 2026 per RSMDF's latest filing, from $559.0 million in the prior quarter.
- Across five years, Finished Goods topped out at $580.5 million in Q3 2025 and bottomed at $320.1 million in Q1 2022.
- Historically, Finished Goods has averaged $500.1 million across 5 years, with a median of $523.8 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Finished Goods jumped 96.76% in 2022, then fell 21.89% in 2024.
- Over 5 years, Finished Goods stood at $522.5 million in 2022, then retreated by 11.38% to $463.0 million in 2023, then rose by 11.16% to $514.7 million in 2024, then rose by 6.14% to $546.3 million in 2025, then increased by 0.13% to $547.0 million in 2026.
- According to Business Quant data, Finished Goods over the past three periods registered $547.0 million, $559.0 million, and $546.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 547.04 Mn |
| Mar 31, 2026 | 558.97 Mn |
| Dec 31, 2025 | 546.35 Mn |
| Sep 30, 2025 | 580.47 Mn |
| Jun 30, 2025 | 557.88 Mn |
| Mar 31, 2025 | 516.38 Mn |
| Dec 31, 2024 | 514.73 Mn |
| Sep 30, 2024 | 542.22 Mn |
| Jun 30, 2024 | 463.97 Mn |
| Mar 31, 2024 | 420.97 Mn |
| Dec 31, 2023 | 463.05 Mn |
| Sep 30, 2023 | 525.18 Mn |
| Jun 30, 2023 | 534.93 Mn |
| Mar 31, 2023 | 538.92 Mn |
| Dec 31, 2022 | 522.50 Mn |
| Sep 30, 2022 | 461.84 Mn |
| Jun 30, 2022 | 385.61 Mn |
| Mar 31, 2022 | 320.13 Mn |
| Dec 31, 2021 | 265.55 Mn |
| Sep 30, 2021 | 282.37 Mn |